share_log

復宏漢霖:自願公告 - 漢斯狀(斯魯利單抗注射液)於印度尼西亞獲批上市,用於治療廣泛期小細胞肺癌(ES-SCLC)

HENLIUS: VOLUNTARY ANNOUNCEMENT - HANSIZHUANG (SERPLULIMAB INJECTION) HAS BEEN APPROVED FOR MARKETING IN INDONESIA FOR THE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)

香港交易所 ·  Dec 28, 2023 07:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more